Syverson Strege & Co’s Diversified Healthcare Trust DHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-740
Closed -$999 209
2023
Q1
$999 Buy
740
+3
+0.4% +$3 ﹤0.01% 603
2022
Q4
$477 Buy
737
+2
+0.3% +$2 ﹤0.01% 300
2022
Q3
$1K Buy
735
+1
+0.1% +$2 ﹤0.01% 263
2022
Q2
$1K Buy
734
+1
+0.1% +$2 ﹤0.01% 310
2022
Q1
$2K Buy
733
+1
+0.1% +$3 ﹤0.01% 269
2021
Q4
$2K Buy
732
+1
+0.1% +$3 ﹤0.01% 268
2021
Q3
$2K Hold
731
﹤0.01% 391
2021
Q2
$3K Buy
731
+1
+0.1% +$4 ﹤0.01% 232
2021
Q1
$3K Buy
730
+1
+0.1% +$5 ﹤0.01% 228
2020
Q4
$3K Buy
+729
New +$2.87K ﹤0.01% 211

Other funds holding DHC

Syverson Strege & Co's DHC Position: Q2 2023 in Review

Syverson Strege & Co sold out of Diversified Healthcare Trust (DHC) in Q2 2023, closing a stake of 740 shares — an estimated $999 sold.

Syverson Strege & Co first reported a position in DHC in Q4 2020 and held it in 10 quarters. The position peaked at $3K in Q2 2021. 160 funds tracked by Wall St. Rank hold DHC as of Q2 2023.

  • Syverson Strege & Co reported no remaining Diversified Healthcare Trust position as of Q2 2023 after selling out during the quarter.
  • Syverson Strege & Co sold 740 Diversified Healthcare Trust shares in Q2 2023, an estimated $999.
  • Syverson Strege & Co first reported a position in Diversified Healthcare Trust in Q4 2020 and held it in 10 quarters.
  • Syverson Strege & Co's Diversified Healthcare Trust position peaked at $3K in Q2 2021.
  • 160 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q2 2023.

Based on Syverson Strege & Co's 13F filing for Q2 2023, filed 4 Aug 2023.